Cargando…
Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Rockefeller University Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620362/ http://dx.doi.org/10.1084/jem.200918462104c |
| _version_ | 1782265584104243200 |
|---|---|
| author | Helfrich, Iris Scheffrahn, Inka Bartling, Sönke Weis, Joachim von Felbert, Verena Middleton, Mark Kato, Masahi Ergün, Süleyman Augustin, Hellmut G. Schadendorf, Dirk |
| author_facet | Helfrich, Iris Scheffrahn, Inka Bartling, Sönke Weis, Joachim von Felbert, Verena Middleton, Mark Kato, Masahi Ergün, Süleyman Augustin, Hellmut G. Schadendorf, Dirk |
| author_sort | Helfrich, Iris |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3620362 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | The Rockefeller University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-36203622013-04-10 Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma Helfrich, Iris Scheffrahn, Inka Bartling, Sönke Weis, Joachim von Felbert, Verena Middleton, Mark Kato, Masahi Ergün, Süleyman Augustin, Hellmut G. Schadendorf, Dirk J Exp Med Correction The Rockefeller University Press 2013-04-08 /pmc/articles/PMC3620362/ http://dx.doi.org/10.1084/jem.200918462104c Text en © 2013 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
| spellingShingle | Correction Helfrich, Iris Scheffrahn, Inka Bartling, Sönke Weis, Joachim von Felbert, Verena Middleton, Mark Kato, Masahi Ergün, Süleyman Augustin, Hellmut G. Schadendorf, Dirk Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma |
| title | Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma |
| title_full | Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma |
| title_fullStr | Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma |
| title_full_unstemmed | Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma |
| title_short | Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma |
| title_sort | resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620362/ http://dx.doi.org/10.1084/jem.200918462104c |
| work_keys_str_mv | AT helfrichiris resistancetoantiangiogenictherapyisdirectedbyvascularphenotypevesselstabilizationandmaturationinmalignantmelanoma AT scheffrahninka resistancetoantiangiogenictherapyisdirectedbyvascularphenotypevesselstabilizationandmaturationinmalignantmelanoma AT bartlingsonke resistancetoantiangiogenictherapyisdirectedbyvascularphenotypevesselstabilizationandmaturationinmalignantmelanoma AT weisjoachim resistancetoantiangiogenictherapyisdirectedbyvascularphenotypevesselstabilizationandmaturationinmalignantmelanoma AT vonfelbertverena resistancetoantiangiogenictherapyisdirectedbyvascularphenotypevesselstabilizationandmaturationinmalignantmelanoma AT middletonmark resistancetoantiangiogenictherapyisdirectedbyvascularphenotypevesselstabilizationandmaturationinmalignantmelanoma AT katomasahi resistancetoantiangiogenictherapyisdirectedbyvascularphenotypevesselstabilizationandmaturationinmalignantmelanoma AT ergunsuleyman resistancetoantiangiogenictherapyisdirectedbyvascularphenotypevesselstabilizationandmaturationinmalignantmelanoma AT augustinhellmutg resistancetoantiangiogenictherapyisdirectedbyvascularphenotypevesselstabilizationandmaturationinmalignantmelanoma AT schadendorfdirk resistancetoantiangiogenictherapyisdirectedbyvascularphenotypevesselstabilizationandmaturationinmalignantmelanoma |